PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2D021D00034610071705! — Sagent Pharmaceuticals, Inc

Sagent Pharmaceuticals, Inc holds $17.2M across 106 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 2 related awards in the incumbent pipeline. Set-aside status: Unrestricted.

Dla Troop Support
Awarding office
Sagent Pharmaceuticals, Inc
Recipient
—
Estimated value
6505
PSC
Unrestricted
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract numberSPE2D021D0003
Also listed asSPE2D0-21-D-0003
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentSagent Pharmaceuticals, Inc
UEIPR1HCLM3FMW7
PSC6505

4610071705! is a federal Unrestricted award for Dla Troop Support held by Sagent Pharmaceuticals, Inc. Estimated value —.

Bonuses end Sept 30

Want the durability read on SPE2D021D0003? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Sagent Pharmaceuticals, Inc — $17.2M obligated across 106 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($17.2M) · all agencies
Department of Health and Human Services (HHS)$16.6M · 97%Department of Defense (DOD)$536K · 3%
Open full company profile →

Related awards

Same incumbent
75A50325F80037
CIPROFLOXACIN SOLUTION FOR INJECTION, 400MG/ 200ML FLEXI-BAG
$16.6M
Sep 30, 2026
SPE2D026F0104
8511940095!OTHER MEDICAL
$149K
Apr 5, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2D021D0003?

SPE2D021D0003 (4610071705!) is a Dla Troop Support award with an estimated value of —, currently held by Sagent Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2D0-21-D-0003?

SPE2D0-21-D-0003 is the dashed form of PIID SPE2D021D0003 (4610071705!), held by Sagent Pharmaceuticals, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2D021D0003?

Dla Troop Support awarded SPE2D021D0003 to Sagent Pharmaceuticals, Inc.

Who is the incumbent on SPE2D021D0003?

Sagent Pharmaceuticals, Inc is the incumbent with $17.2M across 106 related awards in SCOUT’s public footprint.

When does Sagent Pharmaceuticals, Inc’s SPE2D021D0003 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on SPE2D021D0003? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2D021D0003